Analyst Ratings for Jasper Therapeutics (JSPR)
JSPR Rating Summary
JSPR Price Target Summary
- Highest: $17.00 (Rodman & Renshaw)
- Lowest: $1.50 (UBS)
- Average: $6.90
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$6.90 (+675.3%)
* Over Last 12-Mos
Rating Score: 6 / 10
Percentile Rank: 63%
Avg. $ Target:
$6.90 (+675.3%)
* Over Last 12-Mos
Rating Score: 6 / 10
Percentile Rank: 63%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/15/2026 | TD Cowen | Yaron Werber | Downgrade | Hold (Buy) |
N/A (N/A) |
0.96 (0.89) |
-7.29% | Details |
| 3/23/2026 | UBS | David Dai | New Coverage | Neutral (N/A) |
1.50 (N/A) |
1.23 (0.89) |
-27.64% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
